drugset / Trial / NCT01185119

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

NCT01185119

Phase 2/3 Completed 10 enrolled University of Aarhus
RandomizedCrossoverQuadruple-blindBasic science

Summary

10 healthy men will be PET-scanned (CNS) twice in random order with infusions of placebo or Native GLP-1 during hyperglycemic clamp to uncover the metabolic effects of GLP-1 in perspectives of intervention of macrovascular late diabetic pathology such as stroke and AMI. Earlier studies have revealed tendencies towards steady glucose metabolism in the CNS despite fluctuations in blood sugar when infusing native GLP-1.

Timeline

Start
2010-06
Primary completion
2010-12
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Beinaglutide Protein / enzyme biologic 1.2 unknown Other

Indications

No indication recorded.